Active, not recruitingPhase 4NCT06073301
AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF
Studying Necrotizing fasciitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kerecis Ltd.
- Principal Investigator
- Bounthavy Homsombath, MD, MDJoseph M.Still Research Foundation
- Intervention
- Acellular Fish Skin Graft (AFS) with Standard of Care Negative Pressure Wound Therapy (NPWT)(device)
- Enrollment
- 30 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- Joseph M. Still Research Foundation, Augusta, Georgia, United States
Collaborators
Joseph M. Still Research Foundation, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06073301 on ClinicalTrials.gov